Latest news

Clinical

Aligos Therapeutics Secures $25 Million by Granting China Rights for HBV Drug Candidate

Aligos Therapeutics has reached an agreement with hepatology-focused biopharma company Amoytop, obtaining $25 million in upfront cash in exchange...
Commercial

Amneal to Acquire Kashiv BioSciences in Deal Worth Up to $1.1 Billion

Amneal Pharmaceuticals has agreed to acquire Kashiv BioSciences in a transaction valued at up to $1.1 billion, combining cash...
Commercial

Eli Lilly Acquires CrossBridge Bio in Deal Worth Up to $300 Million

Eli Lilly has agreed to acquire CrossBridge Bio, a Houston-based biotechnology company focused on cancer treatments, as part of...
Uncategorized

Top 10 Biotech Companies to Watch in 2026

Executive Summary The biotech industry in 2026 is undergoing a structural shift driven by AI-enabled drug discovery, precision medicine, advanced...
Insights

How Are Macroeconomic Conditions Impacting Pharma and Biotech Funding?

Executive Summary Macroeconomic conditions are significantly reshaping pharma and biotech...
Insights

Top 10 Biotech Podcasts Every Professional Should Listen To in 2026

Executive Summary In 2026, staying ahead in biotech is no...
Insights

Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges

Executive Summary Sustainable practices in pharmaceutical manufacturing in 2026 are transitioning from compliance-driven initiatives to core operational strategy. The direct...
Insights

Top 10 Life Sciences News Platforms for Industry Insights in 2026

  Executive Summary In 2026, staying informed in life sciences is no longer about access to news—it is about access to...
Clinical

AstraZeneca Reports Phase 3 MIRANDA Trial Success for Tozorakimab in COPD

AstraZeneca announced that its experimental drug tozorakimab achieved the primary objective in a late-stage clinical trial focused on chronic...
Commercial

Lilly to Acquire Kelonia for Up to $7 Billion, Adding Phase 1 In Vivo CAR-T Therapy

Eli Lilly has entered into an agreement to acquire...
Regulatory

Roche Initiates Phase III Study of Elevidys Following EMA Feedback

Roche said that it is initiating a late-stage clinical...
Insights

Top 10 Pharma News Websites You Should Follow in 2026

Executive Summary In 2026, pharma and biotech are evolving at unprecedented speed. AI-driven drug discovery, digital transformation, personalized medicine, and...
Insights

How Are Life Sciences Companies Raising Capital in 2026?

Executive Summary In 2026, raising capital in life sciences is no longer about access—it is about proof. The traditional reliance...
Research & Development

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Kailera Therapeutics has provided additional details regarding its planned initial public offering, aiming to raise up to $528.5 million...
Regulatory

Roche Initiates Phase III Study of Elevidys Following EMA Feedback

Roche said that it is initiating a late-stage clinical...
Editorial Team -
Commercial

Amneal to Acquire Kashiv BioSciences in Deal Worth Up to $1.1 Billion

Amneal Pharmaceuticals has agreed to acquire Kashiv BioSciences in...
Editorial Team -
Commercial

Olympus Joins Hands With American Lung Association For Cancer Education

Olympus has joined forces with the American Lung Association...
Commercial

McKesson Invests $2.5B to Acquire Majority Stake in Florida-Based Community Oncology

McKesson has planned to enhance its oncology platform with...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Health technology company PicnicHealth has launched a new product, Virtual Site, which allows researchers...
Editorial Team -

Regulatory

Regulatory

Roche Initiates Phase III Study of Elevidys Following EMA Feedback

Roche said that it is initiating a late-stage clinical...
Editorial Team -
Commercial

Amneal to Acquire Kashiv BioSciences in Deal Worth Up to $1.1 Billion

Amneal Pharmaceuticals has agreed to acquire Kashiv BioSciences in...
Commercial

Eli Lilly Acquires CrossBridge Bio in Deal Worth Up to $300 Million

Eli Lilly has agreed to acquire CrossBridge Bio, a...
Uncategorized

Top 10 Biotech Companies to Watch in 2026

Executive Summary The biotech industry in 2026 is undergoing a...
Insights

Sustainable Practices in Pharmaceutical Manufacturing: Trends and Challenges

Executive Summary Sustainable practices in pharmaceutical manufacturing in 2026 are...

Research & Development

Market Access

Manufacturing

Lilly’s Plan to Build $3B Dutch Plant Underway, 500 Hires Also in the Pipeline

Eli Lilly Expands European Manufacturing with a $3 Billion...
Manufacturing

Alkermes plans to acquire Avadel and its long-acting narcolepsy medication Lumryz for $2.1 billion

Alkermes, which plans to spend up to $2.1 billion...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Clinical

Aligos Therapeutics Secures $25 Million by Granting China Rights for HBV Drug Candidate

Aligos Therapeutics has reached an agreement with hepatology-focused biopharma...
Editorial Team -
Manufacturing

UCB to Build $2 Billion Biologics Manufacturing Facility in Georgia

Belgium-based UCB has announced plans to invest $2 billion...
Editorial Team -